WO1984002193A1 - Chromogenic support immunoassay - Google Patents
Chromogenic support immunoassay Download PDFInfo
- Publication number
 - WO1984002193A1 WO1984002193A1 PCT/US1983/001887 US8301887W WO8402193A1 WO 1984002193 A1 WO1984002193 A1 WO 1984002193A1 US 8301887 W US8301887 W US 8301887W WO 8402193 A1 WO8402193 A1 WO 8402193A1
 - Authority
 - WO
 - WIPO (PCT)
 - Prior art keywords
 - support
 - analyte
 - immunoassay
 - antibody
 - enzyme
 - Prior art date
 
Links
- 238000003018 immunoassay Methods 0.000 title claims abstract description 39
 - 102000004190 Enzymes Human genes 0.000 claims abstract description 65
 - 108090000790 Enzymes Proteins 0.000 claims abstract description 65
 - 238000006243 chemical reaction Methods 0.000 claims abstract description 31
 - 238000001514 detection method Methods 0.000 claims abstract description 11
 - 230000003993 interaction Effects 0.000 claims abstract description 10
 - 239000012472 biological sample Substances 0.000 claims abstract description 9
 - 239000012491 analyte Substances 0.000 claims description 54
 - 239000000427 antigen Substances 0.000 claims description 41
 - 108091007433 antigens Proteins 0.000 claims description 41
 - 102000036639 antigens Human genes 0.000 claims description 41
 - 239000003153 chemical reaction reagent Substances 0.000 claims description 35
 - 108090001090 Lectins Proteins 0.000 claims description 23
 - 102000004856 Lectins Human genes 0.000 claims description 23
 - 239000002523 lectin Substances 0.000 claims description 23
 - 244000005700 microbiome Species 0.000 claims description 18
 - 230000000984 immunochemical effect Effects 0.000 claims description 10
 - 239000004677 Nylon Substances 0.000 claims description 8
 - 239000012911 assay medium Substances 0.000 claims description 8
 - 229920001778 nylon Polymers 0.000 claims description 8
 - 230000015572 biosynthetic process Effects 0.000 claims description 7
 - 125000000524 functional group Chemical group 0.000 claims description 6
 - 239000004952 Polyamide Substances 0.000 claims description 4
 - 229920002647 polyamide Polymers 0.000 claims description 4
 - 238000011533 pre-incubation Methods 0.000 claims description 4
 - 239000001856 Ethyl cellulose Substances 0.000 claims description 2
 - ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 claims description 2
 - 239000000020 Nitrocellulose Substances 0.000 claims description 2
 - FJWGYAHXMCUOOM-QHOUIDNNSA-N [(2s,3r,4s,5r,6r)-2-[(2r,3r,4s,5r,6s)-4,5-dinitrooxy-2-(nitrooxymethyl)-6-[(2r,3r,4s,5r,6s)-4,5,6-trinitrooxy-2-(nitrooxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-3,5-dinitrooxy-6-(nitrooxymethyl)oxan-4-yl] nitrate Chemical compound O([C@@H]1O[C@@H]([C@H]([C@H](O[N+]([O-])=O)[C@H]1O[N+]([O-])=O)O[C@H]1[C@@H]([C@@H](O[N+]([O-])=O)[C@H](O[N+]([O-])=O)[C@@H](CO[N+]([O-])=O)O1)O[N+]([O-])=O)CO[N+](=O)[O-])[C@@H]1[C@@H](CO[N+]([O-])=O)O[C@@H](O[N+]([O-])=O)[C@H](O[N+]([O-])=O)[C@H]1O[N+]([O-])=O FJWGYAHXMCUOOM-QHOUIDNNSA-N 0.000 claims description 2
 - 239000000975 dye Substances 0.000 claims description 2
 - 235000019325 ethyl cellulose Nutrition 0.000 claims description 2
 - 229920001249 ethyl cellulose Polymers 0.000 claims description 2
 - 229920001220 nitrocellulos Polymers 0.000 claims description 2
 - 238000003556 assay Methods 0.000 abstract description 57
 - 239000000758 substrate Substances 0.000 abstract description 19
 - 238000005259 measurement Methods 0.000 abstract description 10
 - 239000000872 buffer Substances 0.000 description 67
 - 229940088598 enzyme Drugs 0.000 description 63
 - 239000000243 solution Substances 0.000 description 41
 - LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 31
 - 239000002953 phosphate buffered saline Substances 0.000 description 31
 - 239000000047 product Substances 0.000 description 30
 - 229920002472 Starch Polymers 0.000 description 27
 - 229940032147 starch Drugs 0.000 description 27
 - 239000008107 starch Substances 0.000 description 27
 - 235000019698 starch Nutrition 0.000 description 27
 - FVAUCKIRQBBSSJ-UHFFFAOYSA-M sodium iodide Chemical compound [Na+].[I-] FVAUCKIRQBBSSJ-UHFFFAOYSA-M 0.000 description 24
 - 238000010790 dilution Methods 0.000 description 23
 - 239000012895 dilution Substances 0.000 description 23
 - 238000000034 method Methods 0.000 description 23
 - 108091003079 Bovine Serum Albumin Proteins 0.000 description 21
 - 229940098773 bovine serum albumin Drugs 0.000 description 21
 - 239000000463 material Substances 0.000 description 21
 - 239000000523 sample Substances 0.000 description 21
 - 238000012360 testing method Methods 0.000 description 19
 - XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 19
 - 210000004027 cell Anatomy 0.000 description 18
 - 238000005406 washing Methods 0.000 description 18
 - 239000011324 bead Substances 0.000 description 14
 - 239000011148 porous material Substances 0.000 description 14
 - 108010001336 Horseradish Peroxidase Proteins 0.000 description 13
 - 229920001213 Polysorbate 20 Polymers 0.000 description 13
 - 241000700605 Viruses Species 0.000 description 13
 - 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 13
 - 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 13
 - CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 12
 - 241000283973 Oryctolagus cuniculus Species 0.000 description 12
 - FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 12
 - KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 12
 - 239000000126 substance Substances 0.000 description 12
 - 229910001868 water Inorganic materials 0.000 description 12
 - 230000027455 binding Effects 0.000 description 11
 - 238000009739 binding Methods 0.000 description 11
 - 239000000203 mixture Substances 0.000 description 11
 - 102000004169 proteins and genes Human genes 0.000 description 11
 - 108090000623 proteins and genes Proteins 0.000 description 11
 - 241000194017 Streptococcus Species 0.000 description 10
 - 239000011521 glass Substances 0.000 description 10
 - 239000008363 phosphate buffer Substances 0.000 description 10
 - 108010015776 Glucose oxidase Proteins 0.000 description 9
 - 239000004366 Glucose oxidase Substances 0.000 description 9
 - 238000007792 addition Methods 0.000 description 9
 - WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 9
 - 229940116332 glucose oxidase Drugs 0.000 description 9
 - 235000019420 glucose oxidase Nutrition 0.000 description 9
 - 239000013610 patient sample Substances 0.000 description 9
 - 239000007795 chemical reaction product Substances 0.000 description 8
 - 238000007654 immersion Methods 0.000 description 8
 - 229920000136 polysorbate Polymers 0.000 description 8
 - 235000009518 sodium iodide Nutrition 0.000 description 8
 - 229920000856 Amylose Polymers 0.000 description 7
 - 241000894006 Bacteria Species 0.000 description 7
 - MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 7
 - 238000001914 filtration Methods 0.000 description 7
 - 238000011534 incubation Methods 0.000 description 7
 - 239000012528 membrane Substances 0.000 description 7
 - 238000002360 preparation method Methods 0.000 description 7
 - 239000011780 sodium chloride Substances 0.000 description 7
 - GHCZTIFQWKKGSB-UHFFFAOYSA-N 2-hydroxypropane-1,2,3-tricarboxylic acid;phosphoric acid Chemical compound OP(O)(O)=O.OC(=O)CC(O)(C(O)=O)CC(O)=O GHCZTIFQWKKGSB-UHFFFAOYSA-N 0.000 description 6
 - 229920000936 Agarose Polymers 0.000 description 6
 - BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 description 6
 - BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 6
 - 241000701022 Cytomegalovirus Species 0.000 description 6
 - 101710146739 Enterotoxin Proteins 0.000 description 6
 - YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 6
 - 230000002378 acidificating effect Effects 0.000 description 6
 - 239000007864 aqueous solution Substances 0.000 description 6
 - 150000001875 compounds Chemical class 0.000 description 6
 - 230000000694 effects Effects 0.000 description 6
 - 239000012530 fluid Substances 0.000 description 6
 - 239000000499 gel Substances 0.000 description 6
 - 239000002245 particle Substances 0.000 description 6
 - -1 poly(acrylamide) Polymers 0.000 description 6
 - 210000002966 serum Anatomy 0.000 description 6
 - 239000007921 spray Substances 0.000 description 6
 - 239000000725 suspension Substances 0.000 description 6
 - 229920000742 Cotton Polymers 0.000 description 5
 - 241000700588 Human alphaherpesvirus 1 Species 0.000 description 5
 - 230000000890 antigenic effect Effects 0.000 description 5
 - 230000001413 cellular effect Effects 0.000 description 5
 - 230000008878 coupling Effects 0.000 description 5
 - 238000010168 coupling process Methods 0.000 description 5
 - 238000005859 coupling reaction Methods 0.000 description 5
 - 239000000147 enterotoxin Substances 0.000 description 5
 - 231100000655 enterotoxin Toxicity 0.000 description 5
 - 230000006870 function Effects 0.000 description 5
 - 239000008187 granular material Substances 0.000 description 5
 - 208000015181 infectious disease Diseases 0.000 description 5
 - 238000002156 mixing Methods 0.000 description 5
 - 239000013642 negative control Substances 0.000 description 5
 - 229920000642 polymer Polymers 0.000 description 5
 - 238000003756 stirring Methods 0.000 description 5
 - 239000003053 toxin Substances 0.000 description 5
 - 231100000765 toxin Toxicity 0.000 description 5
 - 108700012359 toxins Proteins 0.000 description 5
 - GEYOCULIXLDCMW-UHFFFAOYSA-N 1,2-phenylenediamine Chemical compound NC1=CC=CC=C1N GEYOCULIXLDCMW-UHFFFAOYSA-N 0.000 description 4
 - IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
 - 241000283707 Capra Species 0.000 description 4
 - 108060003951 Immunoglobulin Proteins 0.000 description 4
 - 239000007983 Tris buffer Substances 0.000 description 4
 - 238000013459 approach Methods 0.000 description 4
 - 230000008901 benefit Effects 0.000 description 4
 - 239000007979 citrate buffer Substances 0.000 description 4
 - ATDGTVJJHBUTRL-UHFFFAOYSA-N cyanogen bromide Chemical compound BrC#N ATDGTVJJHBUTRL-UHFFFAOYSA-N 0.000 description 4
 - 102000018358 immunoglobulin Human genes 0.000 description 4
 - 230000002458 infectious effect Effects 0.000 description 4
 - 239000004816 latex Substances 0.000 description 4
 - 229920000126 latex Polymers 0.000 description 4
 - 239000007788 liquid Substances 0.000 description 4
 - 239000002736 nonionic surfactant Substances 0.000 description 4
 - 230000004044 response Effects 0.000 description 4
 - 150000003839 salts Chemical class 0.000 description 4
 - 239000007787 solid Substances 0.000 description 4
 - LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 4
 - XZKIHKMTEMTJQX-UHFFFAOYSA-N 4-Nitrophenyl Phosphate Chemical compound OP(O)(=O)OC1=CC=C([N+]([O-])=O)C=C1 XZKIHKMTEMTJQX-UHFFFAOYSA-N 0.000 description 3
 - 108010088751 Albumins Proteins 0.000 description 3
 - 102000009027 Albumins Human genes 0.000 description 3
 - 102000014914 Carrier Proteins Human genes 0.000 description 3
 - LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
 - PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
 - 241001465754 Metazoa Species 0.000 description 3
 - OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
 - 241000700584 Simplexvirus Species 0.000 description 3
 - HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
 - KAPCRJOPWXUMSQ-UHFFFAOYSA-N [2,2-bis[3-(aziridin-1-yl)propanoyloxymethyl]-3-hydroxypropyl] 3-(aziridin-1-yl)propanoate Chemical compound C1CN1CCC(=O)OCC(COC(=O)CCN1CC1)(CO)COC(=O)CCN1CC1 KAPCRJOPWXUMSQ-UHFFFAOYSA-N 0.000 description 3
 - 239000011545 carbonate/bicarbonate buffer Substances 0.000 description 3
 - 238000000576 coating method Methods 0.000 description 3
 - 238000011161 development Methods 0.000 description 3
 - 238000001035 drying Methods 0.000 description 3
 - 210000003743 erythrocyte Anatomy 0.000 description 3
 - 239000012634 fragment Substances 0.000 description 3
 - 239000012678 infectious agent Substances 0.000 description 3
 - 230000004807 localization Effects 0.000 description 3
 - 230000000813 microbial effect Effects 0.000 description 3
 - 229920001223 polyethylene glycol Polymers 0.000 description 3
 - 239000002244 precipitate Substances 0.000 description 3
 - 239000008213 purified water Substances 0.000 description 3
 - 239000011541 reaction mixture Substances 0.000 description 3
 - 238000000926 separation method Methods 0.000 description 3
 - 238000005507 spraying Methods 0.000 description 3
 - 230000003612 virological effect Effects 0.000 description 3
 - GZCWLCBFPRFLKL-UHFFFAOYSA-N 1-prop-2-ynoxypropan-2-ol Chemical compound CC(O)COCC#C GZCWLCBFPRFLKL-UHFFFAOYSA-N 0.000 description 2
 - ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 2
 - 102000013563 Acid Phosphatase Human genes 0.000 description 2
 - 108010051457 Acid Phosphatase Proteins 0.000 description 2
 - HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 2
 - 206010003445 Ascites Diseases 0.000 description 2
 - KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 2
 - 208000035473 Communicable disease Diseases 0.000 description 2
 - 241000588724 Escherichia coli Species 0.000 description 2
 - DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
 - 239000007836 KH2PO4 Substances 0.000 description 2
 - OVRNDRQMDRJTHS-UHFFFAOYSA-N N-acelyl-D-glucosamine Natural products CC(=O)NC1C(O)OC(CO)C(O)C1O OVRNDRQMDRJTHS-UHFFFAOYSA-N 0.000 description 2
 - OVRNDRQMDRJTHS-FMDGEEDCSA-N N-acetyl-beta-D-glucosamine Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-FMDGEEDCSA-N 0.000 description 2
 - MBLBDJOUHNCFQT-LXGUWJNJSA-N N-acetylglucosamine Natural products CC(=O)N[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO MBLBDJOUHNCFQT-LXGUWJNJSA-N 0.000 description 2
 - 229910019142 PO4 Inorganic materials 0.000 description 2
 - 235000019483 Peanut oil Nutrition 0.000 description 2
 - 241001494479 Pecora Species 0.000 description 2
 - 239000004793 Polystyrene Substances 0.000 description 2
 - 229920002684 Sepharose Polymers 0.000 description 2
 - UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
 - 238000005411 Van der Waals force Methods 0.000 description 2
 - 239000002250 absorbent Substances 0.000 description 2
 - 230000002745 absorbent Effects 0.000 description 2
 - 238000001042 affinity chromatography Methods 0.000 description 2
 - BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical class N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 2
 - 238000012870 ammonium sulfate precipitation Methods 0.000 description 2
 - 230000001580 bacterial effect Effects 0.000 description 2
 - 108091008324 binding proteins Proteins 0.000 description 2
 - 210000001124 body fluid Anatomy 0.000 description 2
 - 239000010839 body fluid Substances 0.000 description 2
 - 150000001720 carbohydrates Chemical class 0.000 description 2
 - 235000014633 carbohydrates Nutrition 0.000 description 2
 - PFKFTWBEEFSNDU-UHFFFAOYSA-N carbonyldiimidazole Chemical compound C1=CN=CN1C(=O)N1C=CN=C1 PFKFTWBEEFSNDU-UHFFFAOYSA-N 0.000 description 2
 - 239000000969 carrier Substances 0.000 description 2
 - 230000015556 catabolic process Effects 0.000 description 2
 - 239000003054 catalyst Substances 0.000 description 2
 - 238000006555 catalytic reaction Methods 0.000 description 2
 - 238000005119 centrifugation Methods 0.000 description 2
 - 239000000919 ceramic Substances 0.000 description 2
 - 239000003795 chemical substances by application Substances 0.000 description 2
 - 238000004587 chromatography analysis Methods 0.000 description 2
 - 239000011248 coating agent Substances 0.000 description 2
 - 230000001332 colony forming effect Effects 0.000 description 2
 - 230000000295 complement effect Effects 0.000 description 2
 - 229920001577 copolymer Polymers 0.000 description 2
 - 239000003431 cross linking reagent Substances 0.000 description 2
 - 238000012364 cultivation method Methods 0.000 description 2
 - 238000002405 diagnostic procedure Methods 0.000 description 2
 - 238000007865 diluting Methods 0.000 description 2
 - 239000003085 diluting agent Substances 0.000 description 2
 - BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 2
 - 229910000397 disodium phosphate Inorganic materials 0.000 description 2
 - 239000012153 distilled water Substances 0.000 description 2
 - 229940079593 drug Drugs 0.000 description 2
 - 239000003814 drug Substances 0.000 description 2
 - 239000003792 electrolyte Substances 0.000 description 2
 - 238000010828 elution Methods 0.000 description 2
 - 239000002532 enzyme inhibitor Substances 0.000 description 2
 - 210000003617 erythrocyte membrane Anatomy 0.000 description 2
 - 238000005194 fractionation Methods 0.000 description 2
 - 238000002523 gelfiltration Methods 0.000 description 2
 - 150000004676 glycans Chemical class 0.000 description 2
 - SYECJBOWSGTPLU-UHFFFAOYSA-N hexane-1,1-diamine Chemical compound CCCCCC(N)N SYECJBOWSGTPLU-UHFFFAOYSA-N 0.000 description 2
 - 239000005556 hormone Substances 0.000 description 2
 - 229940088597 hormone Drugs 0.000 description 2
 - 230000007062 hydrolysis Effects 0.000 description 2
 - 238000006460 hydrolysis reaction Methods 0.000 description 2
 - 230000002209 hydrophobic effect Effects 0.000 description 2
 - 230000001900 immune effect Effects 0.000 description 2
 - 229940127121 immunoconjugate Drugs 0.000 description 2
 - 230000002452 interceptive effect Effects 0.000 description 2
 - 229910052740 iodine Inorganic materials 0.000 description 2
 - 239000011630 iodine Substances 0.000 description 2
 - 238000005342 ion exchange Methods 0.000 description 2
 - 238000004255 ion exchange chromatography Methods 0.000 description 2
 - 239000002609 medium Substances 0.000 description 2
 - 230000005012 migration Effects 0.000 description 2
 - 238000013508 migration Methods 0.000 description 2
 - 229910000402 monopotassium phosphate Inorganic materials 0.000 description 2
 - 229950006780 n-acetylglucosamine Drugs 0.000 description 2
 - 229910052757 nitrogen Inorganic materials 0.000 description 2
 - 239000000312 peanut oil Substances 0.000 description 2
 - NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
 - 239000004033 plastic Substances 0.000 description 2
 - 229920003023 plastic Polymers 0.000 description 2
 - 229920002401 polyacrylamide Polymers 0.000 description 2
 - 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 2
 - 229920001282 polysaccharide Polymers 0.000 description 2
 - 239000005017 polysaccharide Substances 0.000 description 2
 - 229920000053 polysorbate 80 Polymers 0.000 description 2
 - 229920002689 polyvinyl acetate Polymers 0.000 description 2
 - 239000011118 polyvinyl acetate Substances 0.000 description 2
 - GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 description 2
 - 238000001556 precipitation Methods 0.000 description 2
 - 230000008569 process Effects 0.000 description 2
 - 102000004196 processed proteins & peptides Human genes 0.000 description 2
 - 108090000765 processed proteins & peptides Proteins 0.000 description 2
 - 238000000746 purification Methods 0.000 description 2
 - 238000003127 radioimmunoassay Methods 0.000 description 2
 - 239000000376 reactant Substances 0.000 description 2
 - 230000009257 reactivity Effects 0.000 description 2
 - 230000000717 retained effect Effects 0.000 description 2
 - 238000012552 review Methods 0.000 description 2
 - 230000035945 sensitivity Effects 0.000 description 2
 - 238000002791 soaking Methods 0.000 description 2
 - 125000006850 spacer group Chemical group 0.000 description 2
 - 230000009870 specific binding Effects 0.000 description 2
 - 238000010561 standard procedure Methods 0.000 description 2
 - 239000011550 stock solution Substances 0.000 description 2
 - 239000004094 surface-active agent Substances 0.000 description 2
 - 239000008399 tap water Substances 0.000 description 2
 - 235000020679 tap water Nutrition 0.000 description 2
 - 210000001519 tissue Anatomy 0.000 description 2
 - 241001529453 unidentified herpesvirus Species 0.000 description 2
 - 230000000007 visual effect Effects 0.000 description 2
 - 238000012800 visualization Methods 0.000 description 2
 - 239000011782 vitamin Substances 0.000 description 2
 - 229940088594 vitamin Drugs 0.000 description 2
 - 235000013343 vitamin Nutrition 0.000 description 2
 - 229930003231 vitamin Natural products 0.000 description 2
 - CHRJZRDFSQHIFI-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;styrene Chemical compound C=CC1=CC=CC=C1.C=CC1=CC=CC=C1C=C CHRJZRDFSQHIFI-UHFFFAOYSA-N 0.000 description 1
 - JVIPLYCGEZUBIO-UHFFFAOYSA-N 2-(4-fluorophenyl)-1,3-dioxoisoindole-5-carboxylic acid Chemical compound O=C1C2=CC(C(=O)O)=CC=C2C(=O)N1C1=CC=C(F)C=C1 JVIPLYCGEZUBIO-UHFFFAOYSA-N 0.000 description 1
 - XCIDNCPEXLYEOP-UHFFFAOYSA-N 2-oxo-1h-pyrazine-3-carbaldehyde Chemical compound OC1=NC=CN=C1C=O XCIDNCPEXLYEOP-UHFFFAOYSA-N 0.000 description 1
 - KIUMMUBSPKGMOY-UHFFFAOYSA-N 3,3'-Dithiobis(6-nitrobenzoic acid) Chemical compound C1=C([N+]([O-])=O)C(C(=O)O)=CC(SSC=2C=C(C(=CC=2)[N+]([O-])=O)C(O)=O)=C1 KIUMMUBSPKGMOY-UHFFFAOYSA-N 0.000 description 1
 - 101710186708 Agglutinin Proteins 0.000 description 1
 - 229920000945 Amylopectin Polymers 0.000 description 1
 - 102000006306 Antigen Receptors Human genes 0.000 description 1
 - 108010083359 Antigen Receptors Proteins 0.000 description 1
 - NOWKCMXCCJGMRR-UHFFFAOYSA-N Aziridine Chemical compound C1CN1 NOWKCMXCCJGMRR-UHFFFAOYSA-N 0.000 description 1
 - 238000009631 Broth culture Methods 0.000 description 1
 - UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
 - 244000025254 Cannabis sativa Species 0.000 description 1
 - 235000012766 Cannabis sativa ssp. sativa var. sativa Nutrition 0.000 description 1
 - 235000012765 Cannabis sativa ssp. sativa var. spontanea Nutrition 0.000 description 1
 - 108090000565 Capsid Proteins Proteins 0.000 description 1
 - 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
 - 108010078791 Carrier Proteins Proteins 0.000 description 1
 - 241000606161 Chlamydia Species 0.000 description 1
 - 108010073254 Colicins Proteins 0.000 description 1
 - 240000000491 Corchorus aestuans Species 0.000 description 1
 - 235000011777 Corchorus aestuans Nutrition 0.000 description 1
 - 235000010862 Corchorus capsularis Nutrition 0.000 description 1
 - GUBGYTABKSRVRQ-WFVLMXAXSA-N DEAE-cellulose Chemical compound OC1C(O)C(O)C(CO)O[C@H]1O[C@@H]1C(CO)OC(O)C(O)C1O GUBGYTABKSRVRQ-WFVLMXAXSA-N 0.000 description 1
 - 229920002307 Dextran Polymers 0.000 description 1
 - 229920001425 Diethylaminoethyl cellulose Polymers 0.000 description 1
 - BRLQWZUYTZBJKN-UHFFFAOYSA-N Epichlorohydrin Chemical compound ClCC1CO1 BRLQWZUYTZBJKN-UHFFFAOYSA-N 0.000 description 1
 - 241000588722 Escherichia Species 0.000 description 1
 - 102000016359 Fibronectins Human genes 0.000 description 1
 - 108010067306 Fibronectins Proteins 0.000 description 1
 - 241000237858 Gastropoda Species 0.000 description 1
 - 108010010803 Gelatin Proteins 0.000 description 1
 - WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
 - 239000004471 Glycine Substances 0.000 description 1
 - 102000003886 Glycoproteins Human genes 0.000 description 1
 - 108090000288 Glycoproteins Proteins 0.000 description 1
 - 241000219146 Gossypium Species 0.000 description 1
 - 241000237369 Helix pomatia Species 0.000 description 1
 - 101710154606 Hemagglutinin Proteins 0.000 description 1
 - 208000032843 Hemorrhage Diseases 0.000 description 1
 - 241000700721 Hepatitis B virus Species 0.000 description 1
 - 208000009889 Herpes Simplex Diseases 0.000 description 1
 - 101710146024 Horcolin Proteins 0.000 description 1
 - 241000701044 Human gammaherpesvirus 4 Species 0.000 description 1
 - XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 description 1
 - 102000018071 Immunoglobulin Fc Fragments Human genes 0.000 description 1
 - 108010091135 Immunoglobulin Fc Fragments Proteins 0.000 description 1
 - 101710189395 Lectin Proteins 0.000 description 1
 - 240000006240 Linum usitatissimum Species 0.000 description 1
 - 235000004431 Linum usitatissimum Nutrition 0.000 description 1
 - 101710179758 Mannose-specific lectin Proteins 0.000 description 1
 - 101710150763 Mannose-specific lectin 1 Proteins 0.000 description 1
 - 101710150745 Mannose-specific lectin 2 Proteins 0.000 description 1
 - 102000012750 Membrane Glycoproteins Human genes 0.000 description 1
 - 108010090054 Membrane Glycoproteins Proteins 0.000 description 1
 - 241000204031 Mycoplasma Species 0.000 description 1
 - 102000005717 Myeloma Proteins Human genes 0.000 description 1
 - 108010045503 Myeloma Proteins Proteins 0.000 description 1
 - KWYHDKDOAIKMQN-UHFFFAOYSA-N N,N,N',N'-tetramethylethylenediamine Chemical compound CN(C)CCN(C)C KWYHDKDOAIKMQN-UHFFFAOYSA-N 0.000 description 1
 - 241000588653 Neisseria Species 0.000 description 1
 - 241000588652 Neisseria gonorrhoeae Species 0.000 description 1
 - 101710093908 Outer capsid protein VP4 Proteins 0.000 description 1
 - 101710135467 Outer capsid protein sigma-1 Proteins 0.000 description 1
 - 239000008118 PEG 6000 Substances 0.000 description 1
 - 241000609499 Palicourea Species 0.000 description 1
 - 206010035226 Plasma cell myeloma Diseases 0.000 description 1
 - 229920002584 Polyethylene Glycol 6000 Polymers 0.000 description 1
 - 239000004353 Polyethylene glycol 8000 Substances 0.000 description 1
 - 101710176177 Protein A56 Proteins 0.000 description 1
 - 229920000297 Rayon Polymers 0.000 description 1
 - 241000606701 Rickettsia Species 0.000 description 1
 - 241000702670 Rotavirus Species 0.000 description 1
 - 241000607142 Salmonella Species 0.000 description 1
 - 229920005654 Sephadex Polymers 0.000 description 1
 - 239000012507 Sephadex™ Substances 0.000 description 1
 - VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
 - 241000295644 Staphylococcaceae Species 0.000 description 1
 - 241000282898 Sus scrofa Species 0.000 description 1
 - 239000013504 Triton X-100 Substances 0.000 description 1
 - 229920004890 Triton X-100 Polymers 0.000 description 1
 - 238000002835 absorbance Methods 0.000 description 1
 - 238000010521 absorption reaction Methods 0.000 description 1
 - 239000008351 acetate buffer Substances 0.000 description 1
 - 239000002253 acid Substances 0.000 description 1
 - NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
 - 230000009471 action Effects 0.000 description 1
 - 230000004913 activation Effects 0.000 description 1
 - 239000003463 adsorbent Substances 0.000 description 1
 - 238000001261 affinity purification Methods 0.000 description 1
 - 239000000910 agglutinin Substances 0.000 description 1
 - ROOXNKNUYICQNP-UHFFFAOYSA-N ammonium peroxydisulfate Substances [NH4+].[NH4+].[O-]S(=O)(=O)OOS([O-])(=O)=O ROOXNKNUYICQNP-UHFFFAOYSA-N 0.000 description 1
 - VAZSKTXWXKYQJF-UHFFFAOYSA-N ammonium persulfate Chemical compound [NH4+].[NH4+].[O-]S(=O)OOS([O-])=O VAZSKTXWXKYQJF-UHFFFAOYSA-N 0.000 description 1
 - 229910001870 ammonium persulfate Inorganic materials 0.000 description 1
 - SOIFLUNRINLCBN-UHFFFAOYSA-N ammonium thiocyanate Chemical compound [NH4+].[S-]C#N SOIFLUNRINLCBN-UHFFFAOYSA-N 0.000 description 1
 - 238000004458 analytical method Methods 0.000 description 1
 - 238000010171 animal model Methods 0.000 description 1
 - 125000000129 anionic group Chemical group 0.000 description 1
 - 230000003602 anti-herpes Effects 0.000 description 1
 - 230000001826 anti-prostatic effect Effects 0.000 description 1
 - 230000000935 anti-streptococcal effect Effects 0.000 description 1
 - 239000012736 aqueous medium Substances 0.000 description 1
 - 239000012298 atmosphere Substances 0.000 description 1
 - 239000000022 bacteriostatic agent Substances 0.000 description 1
 - 238000003287 bathing Methods 0.000 description 1
 - RIIWUGSYXOBDMC-UHFFFAOYSA-N benzene-1,2-diamine;hydron;dichloride Chemical compound Cl.Cl.NC1=CC=CC=C1N RIIWUGSYXOBDMC-UHFFFAOYSA-N 0.000 description 1
 - HFACYLZERDEVSX-UHFFFAOYSA-N benzidine Chemical class C1=CC(N)=CC=C1C1=CC=C(N)C=C1 HFACYLZERDEVSX-UHFFFAOYSA-N 0.000 description 1
 - 230000003115 biocidal effect Effects 0.000 description 1
 - 239000013060 biological fluid Substances 0.000 description 1
 - 229960000074 biopharmaceutical Drugs 0.000 description 1
 - 230000000740 bleeding effect Effects 0.000 description 1
 - 230000000903 blocking effect Effects 0.000 description 1
 - 210000004369 blood Anatomy 0.000 description 1
 - 239000008280 blood Substances 0.000 description 1
 - 239000006161 blood agar Substances 0.000 description 1
 - 229910021538 borax Inorganic materials 0.000 description 1
 - KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
 - 239000004327 boric acid Substances 0.000 description 1
 - 239000006227 byproduct Substances 0.000 description 1
 - 239000001110 calcium chloride Substances 0.000 description 1
 - 229910001628 calcium chloride Inorganic materials 0.000 description 1
 - 235000009120 camo Nutrition 0.000 description 1
 - 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
 - 239000001768 carboxy methyl cellulose Substances 0.000 description 1
 - 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
 - 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
 - 125000002091 cationic group Chemical group 0.000 description 1
 - 230000007910 cell fusion Effects 0.000 description 1
 - 239000013592 cell lysate Substances 0.000 description 1
 - 230000008859 change Effects 0.000 description 1
 - 235000005607 chanvre indien Nutrition 0.000 description 1
 - 239000007810 chemical reaction solvent Substances 0.000 description 1
 - 239000003593 chromogenic compound Substances 0.000 description 1
 - 230000000052 comparative effect Effects 0.000 description 1
 - 230000009918 complex formation Effects 0.000 description 1
 - 230000021615 conjugation Effects 0.000 description 1
 - 238000010580 coupled enzyme reaction Methods 0.000 description 1
 - 239000012531 culture fluid Substances 0.000 description 1
 - 230000003247 decreasing effect Effects 0.000 description 1
 - 239000008367 deionised water Substances 0.000 description 1
 - 229910021641 deionized water Inorganic materials 0.000 description 1
 - 238000000326 densiometry Methods 0.000 description 1
 - 238000013461 design Methods 0.000 description 1
 - 230000014670 detection of bacterium Effects 0.000 description 1
 - 230000010460 detection of virus Effects 0.000 description 1
 - 230000003292 diminished effect Effects 0.000 description 1
 - ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
 - 229910000396 dipotassium phosphate Inorganic materials 0.000 description 1
 - 201000010099 disease Diseases 0.000 description 1
 - 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
 - VIYFPAMJCJLZKD-UHFFFAOYSA-L disodium;(4-nitrophenyl) phosphate Chemical compound [Na+].[Na+].[O-][N+](=O)C1=CC=C(OP([O-])([O-])=O)C=C1 VIYFPAMJCJLZKD-UHFFFAOYSA-L 0.000 description 1
 - UQGFMSUEHSUPRD-UHFFFAOYSA-N disodium;3,7-dioxido-2,4,6,8,9-pentaoxa-1,3,5,7-tetraborabicyclo[3.3.1]nonane Chemical compound [Na+].[Na+].O1B([O-])OB2OB([O-])OB1O2 UQGFMSUEHSUPRD-UHFFFAOYSA-N 0.000 description 1
 - 239000006185 dispersion Substances 0.000 description 1
 - 230000005670 electromagnetic radiation Effects 0.000 description 1
 - 230000002255 enzymatic effect Effects 0.000 description 1
 - 230000007717 exclusion Effects 0.000 description 1
 - 238000002474 experimental method Methods 0.000 description 1
 - 239000000284 extract Substances 0.000 description 1
 - 210000000416 exudates and transudate Anatomy 0.000 description 1
 - 239000004744 fabric Substances 0.000 description 1
 - 210000003608 fece Anatomy 0.000 description 1
 - 238000000855 fermentation Methods 0.000 description 1
 - 230000004151 fermentation Effects 0.000 description 1
 - 239000000835 fiber Substances 0.000 description 1
 - 239000000706 filtrate Substances 0.000 description 1
 - 239000012847 fine chemical Substances 0.000 description 1
 - 235000013373 food additive Nutrition 0.000 description 1
 - 239000002778 food additive Substances 0.000 description 1
 - 238000001641 gel filtration chromatography Methods 0.000 description 1
 - 239000008273 gelatin Substances 0.000 description 1
 - 229920000159 gelatin Polymers 0.000 description 1
 - 235000019322 gelatine Nutrition 0.000 description 1
 - 235000011852 gelatine desserts Nutrition 0.000 description 1
 - 239000003365 glass fiber Substances 0.000 description 1
 - 239000008103 glucose Substances 0.000 description 1
 - 229960002449 glycine Drugs 0.000 description 1
 - 230000036541 health Effects 0.000 description 1
 - 239000000185 hemagglutinin Substances 0.000 description 1
 - 239000011487 hemp Substances 0.000 description 1
 - 208000006454 hepatitis Diseases 0.000 description 1
 - 231100000283 hepatitis Toxicity 0.000 description 1
 - 208000005252 hepatitis A Diseases 0.000 description 1
 - 208000002672 hepatitis B Diseases 0.000 description 1
 - NAQMVNRVTILPCV-UHFFFAOYSA-N hexane-1,6-diamine Chemical compound NCCCCCCN NAQMVNRVTILPCV-UHFFFAOYSA-N 0.000 description 1
 - 210000004408 hybridoma Anatomy 0.000 description 1
 - 239000001257 hydrogen Substances 0.000 description 1
 - 229910052739 hydrogen Inorganic materials 0.000 description 1
 - 125000001165 hydrophobic group Chemical group 0.000 description 1
 - 230000003100 immobilizing effect Effects 0.000 description 1
 - 230000008105 immune reaction Effects 0.000 description 1
 - 230000003053 immunization Effects 0.000 description 1
 - 238000002649 immunization Methods 0.000 description 1
 - 238000005470 impregnation Methods 0.000 description 1
 - 238000000338 in vitro Methods 0.000 description 1
 - 244000000053 intestinal parasite Species 0.000 description 1
 - XMBWDFGMSWQBCA-UHFFFAOYSA-M iodide Chemical compound [I-] XMBWDFGMSWQBCA-UHFFFAOYSA-M 0.000 description 1
 - 229940006461 iodide ion Drugs 0.000 description 1
 - 125000003010 ionic group Chemical group 0.000 description 1
 - 239000003041 laboratory chemical Substances 0.000 description 1
 - 238000003475 lamination Methods 0.000 description 1
 - 150000002605 large molecules Chemical class 0.000 description 1
 - 230000003902 lesion Effects 0.000 description 1
 - 125000005647 linker group Chemical group 0.000 description 1
 - 229920002521 macromolecule Polymers 0.000 description 1
 - 230000014759 maintenance of location Effects 0.000 description 1
 - 150000002689 maleic acids Chemical class 0.000 description 1
 - 238000004519 manufacturing process Methods 0.000 description 1
 - 239000011159 matrix material Substances 0.000 description 1
 - 230000001404 mediated effect Effects 0.000 description 1
 - 239000002207 metabolite Substances 0.000 description 1
 - 229910052751 metal Inorganic materials 0.000 description 1
 - 239000002184 metal Substances 0.000 description 1
 - 239000012982 microporous membrane Substances 0.000 description 1
 - 125000000896 monocarboxylic acid group Chemical group 0.000 description 1
 - 239000000178 monomer Substances 0.000 description 1
 - 201000000050 myeloid neoplasm Diseases 0.000 description 1
 - ZIUHHBKFKCYYJD-UHFFFAOYSA-N n,n'-methylenebisacrylamide Chemical compound C=CC(=O)NCNC(=O)C=C ZIUHHBKFKCYYJD-UHFFFAOYSA-N 0.000 description 1
 - 229920005615 natural polymer Polymers 0.000 description 1
 - 230000009871 nonspecific binding Effects 0.000 description 1
 - 230000003647 oxidation Effects 0.000 description 1
 - 238000007254 oxidation reaction Methods 0.000 description 1
 - 238000012856 packing Methods 0.000 description 1
 - 239000008188 pellet Substances 0.000 description 1
 - 150000002978 peroxides Chemical class 0.000 description 1
 - 239000000575 pesticide Substances 0.000 description 1
 - 239000010452 phosphate Substances 0.000 description 1
 - 210000002381 plasma Anatomy 0.000 description 1
 - 229920000172 poly(styrenesulfonic acid) Polymers 0.000 description 1
 - 229940085678 polyethylene glycol 8000 Drugs 0.000 description 1
 - 235000019446 polyethylene glycol 8000 Nutrition 0.000 description 1
 - 238000006116 polymerization reaction Methods 0.000 description 1
 - 229920001184 polypeptide Polymers 0.000 description 1
 - 229920002223 polystyrene Polymers 0.000 description 1
 - 229940005642 polystyrene sulfonic acid Drugs 0.000 description 1
 - 239000008057 potassium phosphate buffer Substances 0.000 description 1
 - 229920001592 potato starch Polymers 0.000 description 1
 - 239000012460 protein solution Substances 0.000 description 1
 - 238000012205 qualitative assay Methods 0.000 description 1
 - 238000004445 quantitative analysis Methods 0.000 description 1
 - 239000002964 rayon Substances 0.000 description 1
 - 108020003175 receptors Proteins 0.000 description 1
 - 102000005962 receptors Human genes 0.000 description 1
 - 230000002829 reductive effect Effects 0.000 description 1
 - 239000012465 retentate Substances 0.000 description 1
 - 230000002441 reversible effect Effects 0.000 description 1
 - 108010038196 saccharide-binding proteins Proteins 0.000 description 1
 - 238000005070 sampling Methods 0.000 description 1
 - 229920006395 saturated elastomer Polymers 0.000 description 1
 - 238000007790 scraping Methods 0.000 description 1
 - 238000007873 sieving Methods 0.000 description 1
 - 239000002002 slurry Substances 0.000 description 1
 - 239000011734 sodium Substances 0.000 description 1
 - 239000007974 sodium acetate buffer Substances 0.000 description 1
 - 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
 - 229910000033 sodium borohydride Inorganic materials 0.000 description 1
 - 239000012279 sodium borohydride Substances 0.000 description 1
 - 239000012475 sodium chloride buffer Substances 0.000 description 1
 - 229940080313 sodium starch Drugs 0.000 description 1
 - 239000004328 sodium tetraborate Substances 0.000 description 1
 - 235000010339 sodium tetraborate Nutrition 0.000 description 1
 - FYKDNWHPKQOZOT-UHFFFAOYSA-M sodium;dihydrogen phosphate;2-hydroxypropane-1,2,3-tricarboxylic acid Chemical compound [Na+].OP(O)([O-])=O.OC(=O)CC(O)(C(O)=O)CC(O)=O FYKDNWHPKQOZOT-UHFFFAOYSA-M 0.000 description 1
 - 241000894007 species Species 0.000 description 1
 - 239000006228 supernatant Substances 0.000 description 1
 - 229920001059 synthetic polymer Polymers 0.000 description 1
 - 239000012085 test solution Substances 0.000 description 1
 - 125000003698 tetramethyl group Chemical group [H]C([H])([H])* 0.000 description 1
 - 238000002560 therapeutic procedure Methods 0.000 description 1
 - RTKIYNMVFMVABJ-UHFFFAOYSA-L thimerosal Chemical compound [Na+].CC[Hg]SC1=CC=CC=C1C([O-])=O RTKIYNMVFMVABJ-UHFFFAOYSA-L 0.000 description 1
 - 230000007306 turnover Effects 0.000 description 1
 - 238000000108 ultra-filtration Methods 0.000 description 1
 - 239000013026 undiluted sample Substances 0.000 description 1
 - 241000701161 unidentified adenovirus Species 0.000 description 1
 - AQLJVWUFPCUVLO-UHFFFAOYSA-N urea hydrogen peroxide Chemical compound OO.NC(N)=O AQLJVWUFPCUVLO-UHFFFAOYSA-N 0.000 description 1
 - 210000002700 urine Anatomy 0.000 description 1
 - 238000001291 vacuum drying Methods 0.000 description 1
 - 239000011800 void material Substances 0.000 description 1
 
Classifications
- 
        
- G—PHYSICS
 - G01—MEASURING; TESTING
 - G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
 - G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
 - G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
 - G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
 - G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
 - G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
 - G01N33/54353—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals with ligand attached to the carrier via a chemical coupling agent
 
 - 
        
- C—CHEMISTRY; METALLURGY
 - C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
 - C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
 - C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
 - C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
 - C12Q1/24—Methods of sampling, or inoculating or spreading a sample; Methods of physically isolating an intact microorganisms
 
 - 
        
- G—PHYSICS
 - G01—MEASURING; TESTING
 - G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
 - G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
 - G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
 - G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
 - G01N33/52—Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
 - G01N33/521—Single-layer analytical elements
 - G01N33/523—Single-layer analytical elements the element being adapted for a specific analyte
 
 - 
        
- G—PHYSICS
 - G01—MEASURING; TESTING
 - G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
 - G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
 - G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
 - G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
 - G01N33/52—Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
 - G01N33/528—Atypical element structures, e.g. gloves, rods, tampons, toilet paper
 
 - 
        
- G—PHYSICS
 - G01—MEASURING; TESTING
 - G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
 - G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
 - G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
 - G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
 - G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
 - G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
 - G01N33/54306—Solid-phase reaction mechanisms
 
 - 
        
- G—PHYSICS
 - G01—MEASURING; TESTING
 - G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
 - G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
 - G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
 - G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
 - G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
 - G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
 - G01N33/54366—Apparatus specially adapted for solid-phase testing
 - G01N33/54386—Analytical elements
 
 - 
        
- G—PHYSICS
 - G01—MEASURING; TESTING
 - G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
 - G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
 - G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
 - G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
 - G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
 - G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
 - G01N33/544—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being organic
 
 - 
        
- G—PHYSICS
 - G01—MEASURING; TESTING
 - G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
 - G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
 - G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
 - G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
 - G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
 - G01N33/581—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with enzyme label (including co-enzymes, co-factors, enzyme inhibitors or substrates)
 
 - 
        
- G—PHYSICS
 - G01—MEASURING; TESTING
 - G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
 - G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
 - G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
 - G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
 - G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
 - G01N33/6854—Immunoglobulins
 
 
Definitions
- U.S. Patent 4.200,690 issued April 29. 1980 to Root et al., discloses an immunoassay for an intestinal parasite in which the test result is measured by the color which forms on a support.
 - the chromogenic substance used is poorly soluble in the reaction solvent or is preferentially entrapped in the filter matrix in the colored state. Again, precipitation on or preferential binding of the chromogen to the support is largely fortuitous.
 - the assay of this invention can also be performed on filter such as a starch coated glass fiber filter.
 - filter such as a starch coated glass fiber filter.
 - the patient sample can be applied directly to the filter to which antibodies have been previously attached.
 - the antibody utilized in the enzyme-labeled antibody conjugate can be the same as that used to coat the support or it can be an antibody directed to different antigenic determinant on the analyte.
 - the assay of this invention utilizes a nonimmunochemical capture of the analyte. This capture can occur through the physical forces described above or can be mediated by, for example, lectins on the support.
 - the lectins can act in at least two different functions.
 - a lectin can capture all of the microorganisms from a biological sample for which the lectin has specificity.
 - the antianalyte antibody-enzyme conjugate acts to identify the microorganism sought.
 - the lectin itself can serve to capture selectively the microorganism of interest (see footnote 2 above). The microorganism so immobilized on the active support can then be detected by the immunoassay of this invention.
 - the conjugation of the enzyme label to an antibody can be carried out by known methods and in such a way as to minimize both the loss of immunoreactivity of the antibody and the loss of activity of the label. Attachment can be direct or indirect, via a spacer arm. Usually, it is necessary to purify the conjugate extensively before use in the assay in order to remove any unreacted label, unlabeled antibody, and nonimmunoreactive labeled antibody. This can be accomplished by a combination of gel filtration and affinity chromatography steps.
 - the conjugate can be an enzyme-labeled anti-analyte antibody or an enzyme-labeled antibody which is an antibody to an anti-analyte antibody.
 - the product itself is a colored substance; for example, chromogenic substrates such as para-nitrophenyl phosphate and ortho-nitrophenyl galactoside are known for many common enzymes. Chromogen/substrate pairs are also known, for exmple, peroxides and ortho-phenylenediamine for horseradish peroxidase.
 - the product can be less visible or substantially colorless but can become more visible or colored upon interaction with the support.
 - the support can be a starch-coated material which can complex with iodine generated as the product of an enzyme-catalyzed reaction to yield a characteristic blue color on the support.
 - the nonlinearity of color intensity observed was due to the prozone effect, that is, only a single dilution of antibody was utilized in the assay.
 - the control for this assay was performed as above but without HSV antigen.
 - Swabs Composed of polysaccharide fibers such as cotton, flax, hemp, jute, and rayon
 - They are washed with water and then air dried. They are placed in 5 M potassium phosphate buffer. pH 11.9 (25 mL buffer per 1 g of cotton fiber), to which 2 mL of a cyanogen bromide solution (100 mg/mL) is added in small aliquots with gentle stirring over a 2-minute period at 5-10°C. The temperature is maintained for an additional 8 minutes at 5-10°C after which the swabs are washed thoroughly with water and allowed to air dry.
 
Landscapes
- Health & Medical Sciences (AREA)
 - Life Sciences & Earth Sciences (AREA)
 - Immunology (AREA)
 - Engineering & Computer Science (AREA)
 - Chemical & Material Sciences (AREA)
 - Hematology (AREA)
 - Molecular Biology (AREA)
 - Biomedical Technology (AREA)
 - Urology & Nephrology (AREA)
 - Physics & Mathematics (AREA)
 - Microbiology (AREA)
 - Biotechnology (AREA)
 - Analytical Chemistry (AREA)
 - Biochemistry (AREA)
 - General Health & Medical Sciences (AREA)
 - Pathology (AREA)
 - Cell Biology (AREA)
 - Food Science & Technology (AREA)
 - Medicinal Chemistry (AREA)
 - General Physics & Mathematics (AREA)
 - Proteomics, Peptides & Aminoacids (AREA)
 - Organic Chemistry (AREA)
 - Wood Science & Technology (AREA)
 - Zoology (AREA)
 - Chemical Kinetics & Catalysis (AREA)
 - Biophysics (AREA)
 - Bioinformatics & Cheminformatics (AREA)
 - General Engineering & Computer Science (AREA)
 - Genetics & Genomics (AREA)
 - Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
 
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title | 
|---|---|---|---|
| DK375984A DK375984A (da) | 1982-12-03 | 1984-08-02 | Chromogen immunanalyse paa understoetning | 
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title | 
|---|---|---|---|
| US44643482A | 1982-12-03 | 1982-12-03 | |
| US44643382A | 1982-12-03 | 1982-12-03 | 
Publications (1)
| Publication Number | Publication Date | 
|---|---|
| WO1984002193A1 true WO1984002193A1 (en) | 1984-06-07 | 
Family
ID=27034622
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date | 
|---|---|---|---|
| PCT/US1983/001887 WO1984002193A1 (en) | 1982-12-03 | 1983-12-02 | Chromogenic support immunoassay | 
Country Status (3)
| Country | Link | 
|---|---|
| EP (1) | EP0126772A1 (pm) | 
| GR (1) | GR79120B (pm) | 
| WO (1) | WO1984002193A1 (pm) | 
Cited By (28)
| Publication number | Priority date | Publication date | Assignee | Title | 
|---|---|---|---|---|
| EP0212599A3 (en) * | 1985-08-28 | 1987-08-19 | Miles Laboratories, Inc. | Multizone analytical element having detectable signal concentrating zone | 
| EP0191640A3 (en) * | 1985-02-14 | 1987-08-19 | Syntex (U.S.A.) Inc. | Concentrating immunochemical test strip | 
| FR2599845A1 (fr) * | 1986-06-09 | 1987-12-11 | Liotta Lance A | Dispositif pour la determination de la presence d'antigenes dans un echantillon et procede pour sa mise en oeuvre | 
| WO1989001162A1 (en) * | 1987-07-28 | 1989-02-09 | Biotechnology Australia Pty. Ltd. | Detection methods | 
| WO1990009593A1 (en) * | 1989-02-09 | 1990-08-23 | Eastman Kodak Company | Method and kit for determination of herpes simplex viral antigen by direct binding to polymeric particles | 
| US4959307A (en) * | 1986-09-05 | 1990-09-25 | Syntex (U.S.A.) Inc. | Immunoseparating strip | 
| US4963468A (en) * | 1986-09-05 | 1990-10-16 | Syntex (U.S.A.) Inc. | Immunoseparating strip | 
| EP0231010A3 (en) * | 1986-01-27 | 1990-10-17 | INCSTAR Corporation | A method of solid phase enzyme immunoassay and nucleic acid hybridization assay and dip-stick design and stabilized chromogenic substrate | 
| WO1990011523A3 (en) * | 1989-03-29 | 1991-02-21 | Du Pont | Catalyzed reporter deposition | 
| EP0369361A3 (en) * | 1988-11-17 | 1991-06-05 | Becton, Dickinson and Company | Immunoassay on a preblocked solid surface | 
| US5030558A (en) * | 1986-11-07 | 1991-07-09 | Syntex (U.S.A.) Inc. | Qualitative immunochromatographic method and device | 
| US5085988A (en) * | 1986-09-05 | 1992-02-04 | Syntex (U.S.A.) Inc. | Immunoseparating strip | 
| EP0402993A3 (en) * | 1989-06-14 | 1992-03-18 | Johnson & Johnson Clinical Diagnostics, Inc. | Diagnostic test kit and method for determination of chlamydial antigen using a membrane having surface hydroxy groups | 
| WO1992021772A1 (en) * | 1991-05-30 | 1992-12-10 | Abbott Laboratories | Ion-capture assays using a binding member conjugated to carboxymethylamylose | 
| US5196306A (en) * | 1989-03-29 | 1993-03-23 | E. I. Du Pont De Nemours And Company | Method for the detection or quantitation of an analyte using an analyte dependent enzyme activation system | 
| US5260194A (en) * | 1986-09-05 | 1993-11-09 | Syntex (U.S.A.) Inc. | Immunoseparating strip | 
| US5260193A (en) * | 1986-09-05 | 1993-11-09 | Syntex (U.S.A.) Inc. | Immunoseparating strip | 
| US5459080A (en) * | 1988-01-29 | 1995-10-17 | Abbott Laboratories | Ion-capture assays using a specific binding member conjugated to carboxymethylamylose | 
| US5459078A (en) * | 1988-01-29 | 1995-10-17 | Abbott Laboratories | Methods and reagents for performing ion-capture digoxin assays | 
| US5866322A (en) * | 1988-01-29 | 1999-02-02 | Abbott Laboratories | Method for performing Rubella assay | 
| US6887377B2 (en) | 2001-02-01 | 2005-05-03 | Sigma-Aldrich Co. | Affinity matrices with enhanced visibility for molecular pull-down and immunoprecipitation applications | 
| US9128082B2 (en) | 2009-03-24 | 2015-09-08 | Biocept, Inc. | Devices and methods of cell capture and analysis | 
| US9671407B2 (en) | 2009-03-24 | 2017-06-06 | Biocept, Inc. | Devices and methods of cell capture and analysis | 
| US9739773B1 (en) | 2010-08-13 | 2017-08-22 | David Gordon Bermudes | Compositions and methods for determining successful immunization by one or more vaccines | 
| US10865235B2 (en) | 2011-07-18 | 2020-12-15 | President And Fellows Of Harvard College | Engineered microbe-targeting molecules and uses thereof | 
| US11034744B2 (en) | 2013-12-18 | 2021-06-15 | President And Fellows Of Harvard College | CRP capture/detection of gram positive bacteria | 
| US11059874B2 (en) | 2010-01-19 | 2021-07-13 | President And Fellows Of Harvard College | Engineered opsonin for pathogen detection and treatment | 
| US11312949B2 (en) | 2013-05-21 | 2022-04-26 | President And Fellows Of Harvard College | Engineered heme-binding compositions and uses thereof | 
Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title | 
|---|---|---|---|---|
| US4071315A (en) * | 1976-06-02 | 1978-01-31 | Guy Chateau | Analytical tape medium | 
| WO1980002800A1 (en) * | 1979-06-21 | 1980-12-24 | G Oster | Specific impending ovulation indicator | 
| US4289747A (en) * | 1978-12-26 | 1981-09-15 | E-Y Laboratories, Inc. | Immunological determination using lectin | 
| US4299916A (en) * | 1979-12-26 | 1981-11-10 | Syva Company | Preferential signal production on a surface in immunoassays | 
| US4322495A (en) * | 1980-03-11 | 1982-03-30 | Minnesota Mining And Manufacturing Co. | Immunoassay | 
| US4391904A (en) * | 1979-12-26 | 1983-07-05 | Syva Company | Test strip kits in immunoassays and compositions therein | 
| US4407943A (en) * | 1976-12-16 | 1983-10-04 | Millipore Corporation | Immobilized antibody or antigen for immunoassay | 
- 
        1983
        
- 1983-12-02 WO PCT/US1983/001887 patent/WO1984002193A1/en not_active Application Discontinuation
 - 1983-12-02 EP EP84900222A patent/EP0126772A1/en not_active Withdrawn
 - 1983-12-05 GR GR73155A patent/GR79120B/el unknown
 
 
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title | 
|---|---|---|---|---|
| US4071315A (en) * | 1976-06-02 | 1978-01-31 | Guy Chateau | Analytical tape medium | 
| US4407943A (en) * | 1976-12-16 | 1983-10-04 | Millipore Corporation | Immobilized antibody or antigen for immunoassay | 
| US4289747A (en) * | 1978-12-26 | 1981-09-15 | E-Y Laboratories, Inc. | Immunological determination using lectin | 
| WO1980002800A1 (en) * | 1979-06-21 | 1980-12-24 | G Oster | Specific impending ovulation indicator | 
| US4299916A (en) * | 1979-12-26 | 1981-11-10 | Syva Company | Preferential signal production on a surface in immunoassays | 
| US4391904A (en) * | 1979-12-26 | 1983-07-05 | Syva Company | Test strip kits in immunoassays and compositions therein | 
| US4322495A (en) * | 1980-03-11 | 1982-03-30 | Minnesota Mining And Manufacturing Co. | Immunoassay | 
Cited By (44)
| Publication number | Priority date | Publication date | Assignee | Title | 
|---|---|---|---|---|
| EP0191640A3 (en) * | 1985-02-14 | 1987-08-19 | Syntex (U.S.A.) Inc. | Concentrating immunochemical test strip | 
| EP0422699A3 (en) * | 1985-02-14 | 1991-05-08 | Syntex (U.S.A.) Inc. | Methods for binding a compound on bibulous material | 
| US5716778A (en) * | 1985-02-14 | 1998-02-10 | Abbott Laboratories | Concentrating immunochemical test device and method | 
| EP0212599A3 (en) * | 1985-08-28 | 1987-08-19 | Miles Laboratories, Inc. | Multizone analytical element having detectable signal concentrating zone | 
| EP0231010A3 (en) * | 1986-01-27 | 1990-10-17 | INCSTAR Corporation | A method of solid phase enzyme immunoassay and nucleic acid hybridization assay and dip-stick design and stabilized chromogenic substrate | 
| BE1001736A4 (nl) * | 1986-06-09 | 1990-02-20 | Liotta Lance A | Gelaagde immunoassay waarbij antilichamen worden gebruikt die gebonden zijn aan transportdeeltjes, voor het bepalen van de aanwezigheid van een antigeen. | 
| FR2599845A1 (fr) * | 1986-06-09 | 1987-12-11 | Liotta Lance A | Dispositif pour la determination de la presence d'antigenes dans un echantillon et procede pour sa mise en oeuvre | 
| US4959307A (en) * | 1986-09-05 | 1990-09-25 | Syntex (U.S.A.) Inc. | Immunoseparating strip | 
| US4963468A (en) * | 1986-09-05 | 1990-10-16 | Syntex (U.S.A.) Inc. | Immunoseparating strip | 
| US5260194A (en) * | 1986-09-05 | 1993-11-09 | Syntex (U.S.A.) Inc. | Immunoseparating strip | 
| US5085988A (en) * | 1986-09-05 | 1992-02-04 | Syntex (U.S.A.) Inc. | Immunoseparating strip | 
| US5260193A (en) * | 1986-09-05 | 1993-11-09 | Syntex (U.S.A.) Inc. | Immunoseparating strip | 
| US5030558A (en) * | 1986-11-07 | 1991-07-09 | Syntex (U.S.A.) Inc. | Qualitative immunochromatographic method and device | 
| WO1989001162A1 (en) * | 1987-07-28 | 1989-02-09 | Biotechnology Australia Pty. Ltd. | Detection methods | 
| US5866322A (en) * | 1988-01-29 | 1999-02-02 | Abbott Laboratories | Method for performing Rubella assay | 
| US5459078A (en) * | 1988-01-29 | 1995-10-17 | Abbott Laboratories | Methods and reagents for performing ion-capture digoxin assays | 
| US5459080A (en) * | 1988-01-29 | 1995-10-17 | Abbott Laboratories | Ion-capture assays using a specific binding member conjugated to carboxymethylamylose | 
| EP0369361A3 (en) * | 1988-11-17 | 1991-06-05 | Becton, Dickinson and Company | Immunoassay on a preblocked solid surface | 
| US6235464B1 (en) | 1988-11-17 | 2001-05-22 | Glenn L. Henderson | Immunoassay on a preblocked solid surface | 
| WO1990009593A1 (en) * | 1989-02-09 | 1990-08-23 | Eastman Kodak Company | Method and kit for determination of herpes simplex viral antigen by direct binding to polymeric particles | 
| US5196306A (en) * | 1989-03-29 | 1993-03-23 | E. I. Du Pont De Nemours And Company | Method for the detection or quantitation of an analyte using an analyte dependent enzyme activation system | 
| US5583001A (en) * | 1989-03-29 | 1996-12-10 | E. I. Du Pont De Nemours And Company | Method for detection or quantitation of an analyte using an analyte dependent enzyme activation system | 
| WO1990011523A3 (en) * | 1989-03-29 | 1991-02-21 | Du Pont | Catalyzed reporter deposition | 
| US5731158A (en) * | 1989-03-29 | 1998-03-24 | E. I. Du Pont De Nemours And Company | Catalyzed reporter deposition | 
| EP0402993A3 (en) * | 1989-06-14 | 1992-03-18 | Johnson & Johnson Clinical Diagnostics, Inc. | Diagnostic test kit and method for determination of chlamydial antigen using a membrane having surface hydroxy groups | 
| WO1992021772A1 (en) * | 1991-05-30 | 1992-12-10 | Abbott Laboratories | Ion-capture assays using a binding member conjugated to carboxymethylamylose | 
| US6887377B2 (en) | 2001-02-01 | 2005-05-03 | Sigma-Aldrich Co. | Affinity matrices with enhanced visibility for molecular pull-down and immunoprecipitation applications | 
| US7163633B2 (en) | 2001-02-01 | 2007-01-16 | Sigma-Aldrich Co. | Affinity matrices with enhanced visibility for molecular pull-down and immunoprecipitation applications | 
| US7438806B2 (en) | 2001-02-01 | 2008-10-21 | Sigma-Aldrich Co. | Affinity matrices with enhanced visibility for molecular pull-down and immunoprecipitation applications | 
| EP2411808B1 (en) * | 2009-03-24 | 2015-11-11 | Biocept, Inc. | Devices and methods of cell capture and analysis | 
| US9128082B2 (en) | 2009-03-24 | 2015-09-08 | Biocept, Inc. | Devices and methods of cell capture and analysis | 
| US9671407B2 (en) | 2009-03-24 | 2017-06-06 | Biocept, Inc. | Devices and methods of cell capture and analysis | 
| US11719692B2 (en) | 2009-03-24 | 2023-08-08 | Biocept, Inc. | Devices and methods of cell capture and analysis | 
| US10527611B2 (en) | 2009-03-24 | 2020-01-07 | Biocept, Inc. | Devices and methods of cell capture and analysis | 
| US11059874B2 (en) | 2010-01-19 | 2021-07-13 | President And Fellows Of Harvard College | Engineered opsonin for pathogen detection and treatment | 
| US11059873B2 (en) | 2010-01-19 | 2021-07-13 | President And Fellows Of Harvard College | Engineered opsonin for pathogen detection and treatment | 
| US11203623B2 (en) | 2010-01-19 | 2021-12-21 | President And Fellows Of Harvard College | Engineered opsonin for pathogen detection and treatment | 
| US9739773B1 (en) | 2010-08-13 | 2017-08-22 | David Gordon Bermudes | Compositions and methods for determining successful immunization by one or more vaccines | 
| US10865235B2 (en) | 2011-07-18 | 2020-12-15 | President And Fellows Of Harvard College | Engineered microbe-targeting molecules and uses thereof | 
| US11795212B2 (en) | 2011-07-18 | 2023-10-24 | President And Fellows Of Harvard College | Engineered microbe-targeting molecules and uses thereof | 
| US11312949B2 (en) | 2013-05-21 | 2022-04-26 | President And Fellows Of Harvard College | Engineered heme-binding compositions and uses thereof | 
| US11939608B2 (en) | 2013-05-21 | 2024-03-26 | President And Fellows Of Harvard College | Engineered heme-binding compositions and uses thereof | 
| US11034744B2 (en) | 2013-12-18 | 2021-06-15 | President And Fellows Of Harvard College | CRP capture/detection of gram positive bacteria | 
| US11718651B2 (en) | 2013-12-18 | 2023-08-08 | President And Fellows Of Harvard College | CRP capture/detection of gram positive bacteria | 
Also Published As
| Publication number | Publication date | 
|---|---|
| GR79120B (pm) | 1984-10-02 | 
| EP0126772A1 (en) | 1984-12-05 | 
Similar Documents
| Publication | Publication Date | Title | 
|---|---|---|
| WO1984002193A1 (en) | Chromogenic support immunoassay | |
| US4948726A (en) | Enzyme immunoassay based on membrane separation of antigen-antibody complexes | |
| US4853335A (en) | Colloidal gold particle concentration immunoassay | |
| AU592540B2 (en) | Field assay for ligands | |
| Yolken | Enzyme-linked immunosorbent assay (ELISA): a practical tool for rapid diagnosis of viruses and other infectious agents | |
| US5501949A (en) | Particle bound binding component immunoassay | |
| EP0051183B1 (en) | Multilayer analysis element | |
| AU748387B2 (en) | Neutralization of polycations in a chromatographic device for whole blood use | |
| EP2063269B1 (en) | Chromatography apparatus for detecting Staphylococcus aureus | |
| CA1272127A (en) | Solid phase system for use in ligand-receptor assays | |
| US5169757A (en) | Antibodies or antigens bound to a macroporous hydrophobic synthetic polymer cloth for immunological techniques | |
| EP0124352B1 (en) | Protected binding assay | |
| JPS62501989A (ja) | 酵素免疫法による臨床パラメ−タ−の測定法 | |
| JPH0312705B2 (pm) | ||
| WO1987003690A1 (en) | Particle-bound binding component immunoassay | |
| US5122452A (en) | Enzyme immunoassay with a macroporous hydrophobic synthetic polymer cloth containing an immobilized antibody or antigen | |
| JP3609240B2 (ja) | 免疫学的検査法および免疫学的検査用キット | |
| EP0268296B1 (en) | Membrane affinity concentration immunoassay | |
| AU2247192A (en) | Assay for the detection of specific ligands | |
| JPS60500548A (ja) | 発色性支持体免疫測定法 | |
| EP0152254A2 (en) | Chromogenic support immunoassay utilizing labeled complement components | |
| WO2008080031A9 (en) | Chromatographic test strips for one or more analytes | |
| CA2019048C (en) | Cloth enzyme immunoassay | |
| US5206178A (en) | Membrane affinity concentration immunoassay | |
| Penney et al. | Polycarbonate membranes: a novel surface for solid-phase determinations with utility in field format serological assays | 
Legal Events
| Date | Code | Title | Description | 
|---|---|---|---|
| AK | Designated states | 
             Designated state(s): DK JP  | 
        |
| AL | Designated countries for regional patents | 
             Designated state(s): BE DE FR GB LU NL  | 
        |
| WWE | Wipo information: entry into national phase | 
             Ref document number: 1984900222 Country of ref document: EP  | 
        |
| WWP | Wipo information: published in national office | 
             Ref document number: 1984900222 Country of ref document: EP  | 
        |
| WWW | Wipo information: withdrawn in national office | 
             Ref document number: 1984900222 Country of ref document: EP  |